• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MRO
Click for more information
3.45% 6.0¢

MONARO MINING NL

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MRO
adr listing 		18/05/10 2 1.1K
18/05/10 Last post  mraj Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 
MRO
sicker! 		13/05/10 2 708
13/05/10 Last post  Brettox Comments Created with Sketch.  2  Views Created with Sketch.  708 
MRO
Ann: Change of Director's Interest Notice - M 		12/05/10 0 338
12/05/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  338 
MRO
offshore benefits 		04/05/10 0 388
04/05/10 Last post  mraj Comments Created with Sketch.  0  Views Created with Sketch.  388 
MRO
Ann: Quarterly Cashflow Report 		30/04/10 0 314
30/04/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  314 
MRO
Ann: Quarterly Activities Report 		30/04/10 0 323
30/04/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  323 
MRO
Ann: Company Presentation of 28 April 2010 - Clar 		30/04/10 0 281
30/04/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  281 
MRO
Ann: Company Update of 28 April 2010 - Clarified 		30/04/10 0 246
30/04/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  246 

See All Discussions arrow Created with Sketch.

Top Stories

HotCopper Highlights: Your most watched stocks for Week 46, 2024

What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.